Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000367091 | SCV000334676 | likely benign | not specified | 2015-08-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000367091 | SCV000516057 | likely benign | not specified | 2017-08-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000639504 | SCV000761079 | benign | Carnitine palmitoyl transferase 1A deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001092910 | SCV001249647 | likely benign | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001092910 | SCV005219288 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001092910 | SCV001959421 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001092910 | SCV001967232 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000639504 | SCV002092939 | likely benign | Carnitine palmitoyl transferase 1A deficiency | 2019-12-06 | no assertion criteria provided | clinical testing |